nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A5—Niacin—atherosclerosis	0.464	1	CbGbCtD
Norepinephrine—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	3.2e-05	5.97e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PDGFB—atherosclerosis	3.19e-05	5.94e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—F2—atherosclerosis	3.17e-05	5.91e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.17e-05	5.91e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	3.16e-05	5.9e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	3.16e-05	5.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ALB—atherosclerosis	3.15e-05	5.87e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	3.14e-05	5.85e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SERPINE1—atherosclerosis	3.12e-05	5.83e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—MAPK3—atherosclerosis	3.12e-05	5.82e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—F2—atherosclerosis	3.12e-05	5.81e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AGT—atherosclerosis	3.11e-05	5.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	3.11e-05	5.79e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—INS—atherosclerosis	3.1e-05	5.78e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—NOS3—atherosclerosis	3.09e-05	5.77e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	3.08e-05	5.75e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—HMGCR—atherosclerosis	3.07e-05	5.73e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—INS—atherosclerosis	3.07e-05	5.73e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	3.07e-05	5.72e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	3.07e-05	5.72e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	3.07e-05	5.72e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCL2—atherosclerosis	3.05e-05	5.69e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APOE—atherosclerosis	3.05e-05	5.68e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—LEP—atherosclerosis	3.05e-05	5.68e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—INS—atherosclerosis	3.03e-05	5.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	3.03e-05	5.65e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TGFB1—atherosclerosis	3.03e-05	5.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	3.02e-05	5.64e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CAV1—atherosclerosis	3.02e-05	5.63e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ALB—atherosclerosis	3.01e-05	5.62e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APOA1—atherosclerosis	3.01e-05	5.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—NOS3—atherosclerosis	3.01e-05	5.61e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IGF1—atherosclerosis	3e-05	5.59e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AGT—atherosclerosis	3e-05	5.59e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCL2—atherosclerosis	2.98e-05	5.56e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	2.98e-05	5.56e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	2.98e-05	5.56e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	2.97e-05	5.54e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CG—atherosclerosis	2.94e-05	5.49e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—LEP—atherosclerosis	2.94e-05	5.47e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOE—atherosclerosis	2.94e-05	5.47e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IGF1—atherosclerosis	2.93e-05	5.47e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ESR1—atherosclerosis	2.91e-05	5.42e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	2.91e-05	5.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	2.9e-05	5.41e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	2.9e-05	5.41e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—NOS3—atherosclerosis	2.88e-05	5.38e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—F2—atherosclerosis	2.87e-05	5.36e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—INS—atherosclerosis	2.87e-05	5.35e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	2.86e-05	5.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	2.85e-05	5.32e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	2.85e-05	5.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PPARG—atherosclerosis	2.84e-05	5.3e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PTGS2—atherosclerosis	2.83e-05	5.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—INS—atherosclerosis	2.82e-05	5.27e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	2.82e-05	5.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	2.82e-05	5.26e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	2.8e-05	5.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—INS—atherosclerosis	2.79e-05	5.2e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	2.78e-05	5.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AGT—atherosclerosis	2.78e-05	5.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	2.78e-05	5.18e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	2.77e-05	5.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—AKT1—atherosclerosis	2.77e-05	5.17e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.77e-05	5.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—F2—atherosclerosis	2.77e-05	5.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PTGS2—atherosclerosis	2.75e-05	5.13e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	2.75e-05	5.13e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ABCA1—atherosclerosis	2.74e-05	5.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	2.73e-05	5.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOE—atherosclerosis	2.73e-05	5.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—LEP—atherosclerosis	2.73e-05	5.09e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NOS3—atherosclerosis	2.72e-05	5.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	2.7e-05	5.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	2.7e-05	5.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	2.69e-05	5.02e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NOS3—atherosclerosis	2.66e-05	4.96e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	2.65e-05	4.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	2.65e-05	4.93e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PTGS2—atherosclerosis	2.64e-05	4.92e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	2.64e-05	4.91e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	2.63e-05	4.91e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	2.6e-05	4.86e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—INS—atherosclerosis	2.6e-05	4.85e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	2.59e-05	4.84e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—F2—atherosclerosis	2.57e-05	4.8e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL2—atherosclerosis	2.56e-05	4.78e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	2.56e-05	4.77e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ALB—atherosclerosis	2.55e-05	4.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	2.54e-05	4.73e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IGF1—atherosclerosis	2.52e-05	4.7e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	2.52e-05	4.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	2.52e-05	4.69e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—INS—atherosclerosis	2.51e-05	4.68e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	2.48e-05	4.62e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	2.47e-05	4.6e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	2.46e-05	4.59e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—NOS3—atherosclerosis	2.44e-05	4.56e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	2.43e-05	4.52e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	2.41e-05	4.5e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	2.39e-05	4.46e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	2.39e-05	4.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	2.39e-05	4.46e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	2.37e-05	4.42e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	2.36e-05	4.4e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	2.36e-05	4.4e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—HMOX1—atherosclerosis	2.35e-05	4.38e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—INS—atherosclerosis	2.33e-05	4.35e-05	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	2.33e-05	4.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	2.33e-05	4.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	2.32e-05	4.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	2.31e-05	4.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	2.3e-05	4.3e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL6—atherosclerosis	2.29e-05	4.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	2.29e-05	4.28e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NOS3—atherosclerosis	2.28e-05	4.26e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL6—atherosclerosis	2.28e-05	4.26e-05	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	2.28e-05	4.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	2.27e-05	4.24e-05	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—AKT1—atherosclerosis	2.27e-05	4.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	2.25e-05	4.2e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOB—atherosclerosis	2.25e-05	4.2e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—atherosclerosis	2.24e-05	4.18e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTGS2—atherosclerosis	2.24e-05	4.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	2.23e-05	4.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	2.2e-05	4.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	2.2e-05	4.1e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.19e-05	4.08e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—atherosclerosis	2.18e-05	4.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	2.16e-05	4.03e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	2.16e-05	4.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	2.16e-05	4.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	2.15e-05	4.01e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—LPL—atherosclerosis	2.15e-05	4.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	2.14e-05	3.99e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	2.14e-05	3.99e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—atherosclerosis	2.13e-05	3.98e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	2.13e-05	3.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	2.12e-05	3.96e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	2.12e-05	3.96e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	2.12e-05	3.96e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	2.12e-05	3.94e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	2.11e-05	3.94e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—atherosclerosis	2.11e-05	3.93e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	2.1e-05	3.92e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GPX1—atherosclerosis	2.1e-05	3.91e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	2.1e-05	3.91e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	2.09e-05	3.89e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	2.07e-05	3.87e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	2.07e-05	3.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	2.04e-05	3.81e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CD36—atherosclerosis	2.04e-05	3.81e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	2.03e-05	3.79e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	2.02e-05	3.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	2.02e-05	3.76e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	2e-05	3.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	1.99e-05	3.7e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	1.97e-05	3.68e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	1.97e-05	3.67e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	1.96e-05	3.66e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	1.96e-05	3.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	1.96e-05	3.65e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	1.96e-05	3.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	1.95e-05	3.64e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	1.94e-05	3.62e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—atherosclerosis	1.94e-05	3.62e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.93e-05	3.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	1.93e-05	3.6e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	1.93e-05	3.59e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—atherosclerosis	1.93e-05	3.59e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	1.92e-05	3.58e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	1.92e-05	3.57e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARA—atherosclerosis	1.9e-05	3.54e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—atherosclerosis	1.9e-05	3.54e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	1.88e-05	3.51e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	1.86e-05	3.46e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	1.85e-05	3.45e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AGT—atherosclerosis	1.84e-05	3.43e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	1.84e-05	3.42e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—atherosclerosis	1.83e-05	3.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	1.81e-05	3.38e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	1.81e-05	3.38e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	1.81e-05	3.38e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	1.81e-05	3.38e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOE—atherosclerosis	1.8e-05	3.36e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	1.8e-05	3.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	1.79e-05	3.35e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CAV1—atherosclerosis	1.78e-05	3.33e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	1.78e-05	3.33e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	1.78e-05	3.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	1.78e-05	3.32e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOA1—atherosclerosis	1.78e-05	3.32e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	1.78e-05	3.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	1.77e-05	3.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	1.76e-05	3.29e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	1.76e-05	3.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	1.75e-05	3.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	1.75e-05	3.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	1.72e-05	3.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	1.72e-05	3.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	1.71e-05	3.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	1.71e-05	3.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	1.69e-05	3.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	1.66e-05	3.1e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	1.64e-05	3.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	1.64e-05	3.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	1.64e-05	3.05e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—atherosclerosis	1.63e-05	3.04e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.63e-05	3.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	1.62e-05	3.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	1.59e-05	2.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	1.59e-05	2.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.58e-05	2.95e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.57e-05	2.93e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARG—atherosclerosis	1.57e-05	2.92e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	1.56e-05	2.9e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—INS—atherosclerosis	1.54e-05	2.87e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	1.51e-05	2.81e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.5e-05	2.8e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—atherosclerosis	1.49e-05	2.77e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	1.47e-05	2.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	1.46e-05	2.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.45e-05	2.71e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—atherosclerosis	1.42e-05	2.65e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—atherosclerosis	1.41e-05	2.63e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	1.39e-05	2.6e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—atherosclerosis	1.38e-05	2.58e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	1.37e-05	2.56e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—atherosclerosis	1.35e-05	2.53e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	1.35e-05	2.52e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NOS3—atherosclerosis	1.35e-05	2.52e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—atherosclerosis	1.34e-05	2.5e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—atherosclerosis	1.33e-05	2.47e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—atherosclerosis	1.32e-05	2.47e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—atherosclerosis	1.25e-05	2.34e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—atherosclerosis	1.25e-05	2.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	1.24e-05	2.31e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.23e-05	2.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	1.23e-05	2.3e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—atherosclerosis	1.22e-05	2.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	1.16e-05	2.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.14e-05	2.12e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—atherosclerosis	1.14e-05	2.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—atherosclerosis	1.12e-05	2.09e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.1e-05	2.04e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.05e-05	1.96e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.02e-05	1.9e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.01e-05	1.89e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	9.39e-06	1.75e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—atherosclerosis	6.2e-06	1.16e-05	CbGpPWpGaD
